765 related articles for article (PubMed ID: 31336149)
1. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
[TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
3. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
[TBL] [Abstract][Full Text] [Related]
4. The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes.
Hörbelt T; Tacke C; Markova M; Herzfeld de Wiza D; Van de Velde F; Bekaert M; Van Nieuwenhove Y; Hornemann S; Rödiger M; Seebeck N; Friedl E; Jonas W; Thoresen GH; Kuss O; Rosenthal A; Lange V; Pfeiffer AFH; Schürmann A; Lapauw B; Rudovich N; Pivovarova O; Ouwens DM
Diabetologia; 2018 Sep; 61(9):2054-2065. PubMed ID: 29754289
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
6. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
8. Physiological Disturbance in Fatty Liver Energy Metabolism Converges on IGFBP2 Abundance and Regulation in Mice and Men.
Fahlbusch P; Knebel B; Hörbelt T; Barbosa DM; Nikolic A; Jacob S; Al-Hasani H; Van de Velde F; Van Nieuwenhove Y; Müller-Wieland D; Lapauw B; Ouwens DM; Kotzka J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532003
[TBL] [Abstract][Full Text] [Related]
9. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
10. Adipokinome Signatures in Obese Mouse Models Reflect Adipose Tissue Health and Are Associated with Serum Lipid Composition.
Knebel B; Fahlbusch P; Poschmann G; Dille M; Wahlers N; Stühler K; Hartwig S; Lehr S; Schiller M; Jacob S; Kettel U; Müller-Wieland D; Kotzka J
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137678
[TBL] [Abstract][Full Text] [Related]
11. Direct and systemic actions of growth hormone receptor (GHR)-signaling on hepatic glycolysis, de novo lipogenesis and insulin sensitivity, associated with steatosis.
Vázquez-Borrego MC; Del Río-Moreno M; Pyatkov M; Sarmento-Cabral A; Mahmood M; Pelke N; Wnek M; Cordoba-Chacon J; Waxman DJ; Puchowicz MA; McGuinness OP; Kineman RD
Metabolism; 2023 Jul; 144():155589. PubMed ID: 37182789
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
13. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
14. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.
Shannon CE; Ragavan M; Palavicini JP; Fourcaudot M; Bakewell TM; Valdez IA; Ayala I; Jin ES; Madesh M; Han X; Merritt ME; Norton L
Mol Metab; 2021 Mar; 45():101154. PubMed ID: 33359401
[TBL] [Abstract][Full Text] [Related]
16. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
17. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
[TBL] [Abstract][Full Text] [Related]
18. Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1.
Wang S; Liu T; Sun L; Du H; Xu Z; Li R; Yu Y; Mao Y; Shi K
Mol Cell Biochem; 2022 May; 477(5):1555-1568. PubMed ID: 35182330
[TBL] [Abstract][Full Text] [Related]
19. Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice.
Irimia JM; Meyer CM; Segvich DM; Surendran S; DePaoli-Roach AA; Morral N; Roach PJ
J Biol Chem; 2017 Jun; 292(25):10455-10464. PubMed ID: 28483921
[TBL] [Abstract][Full Text] [Related]
20. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]